Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterNo recent work listed

Sonja Loges

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7650-8527; OpenAlex author ID A5022181207. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 1 paper

Papers 3

  1. The HDL particle composition determines its antitumor activity in pancreatic cancer. Co-author DOI 10.26508/lsa.202101317↗
  2. Lorlatinib Induces Durable Disease Stabilization in a Pancreatic Cancer Patient with a ROS1 p.L1950F Mutation: Case Report. Last author DOI 10.1159/000517616↗
  3. GAS2L1 Is a Potential Biomarker of Circulating Tumor Cells in Pancreatic Cancer. Co-author DOI 10.3390/cancers12123774↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Janna-Lisa Velthaus · 1 shared paper, 2021 · strength 0.13
  2. Raimund Oberle · 1 shared paper, 2022 · strength 0.13
  3. Matthias Unseld · 1 shared paper, 2022 · strength 0.13
  4. Herbert Stangl · 1 shared paper, 2022 · strength 0.13
  5. Lei Zhu · 1 shared paper, 2020 · strength 0.11
  6. Balázs Győrffy · 1 shared paper, 2020 · strength 0.11
  7. Cui Yang · 1 shared paper, 2020 · strength 0.11
  8. Christoph Reißfelder · 1 shared paper, 2020 · strength 0.11
  9. Sebastian Schölch · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.